The diagnostic approach to allergic disease has significantly been improved by the Component-Resolved Diagnosis (CRD), which provides information about patients’ sensitization at the molecular component level by integrating the Skin Prick Test (SPT) and the specific IgE assay with extractive allergen results. The gene discussed is IGHE; the disease is allergic disease.